Malvern Treatment Centers

Stay Connected With Malvern. Get Email Updates | Follow Us:

FDA showing support for Medication Assisted Treatment methods

December 5, 2017 – Medication Assisted Treatment (MAT) has proven effective in treating the disease of addiction, and federal officials are encouraging more widespread use of MAT programming.

This week, the U.S. Food and Drug Administration approved Sublocade, a new monthly injection of buprenorphine (Suboxone) for patients to ease withdrawal symptoms, reports Newsweek. Unlike Vivitrol, Sublocade won’t require detoxification before the injection.

Malvern’s MAT program is highly structured, and the medication offered is only one aspect of the treatment protocol. Currently, MAT programs are available at both inpatient campuses in Malvern and Willow Grove, as well as outpatient locations in Trevose, Berwynand Cherry Hill.

From the report:

“It’s potentially a game changer,” Dr. Andrew Kolodny, co-director of opioid policy research at Brandeis University, told STAT. “This could become first-line [medication] for opioid addiction. It could open up opportunities for getting more patients buprenorphine.”

Individor, a London-based pharmaceuticals group, are the creators of the newly approved injectable product called Sublocade. In an FDA voting session, an overwhelming majority of the committee (18-1) supported the approval of Sublocade, Reuters reports.

Malvern Treatment Centers: We Give Hope

If you or a loved one are living with addiction, we can help. Learn about Malvern Intervention Services or the Malvern 90-Day Model by calling 610.MALVERN (610.625.8376).

Read the full story on Newsweek.


Recent News

Dr. Peter Swanljung Appointed to Chief Medical Officer

Malvern Health is proud to announce that Dr. Peter Swanljung has been appointed as our new Chief Medical Officer.  Dr. Swanljung will be responsible for the physician and medical oversight of all of our bed-based services including our two Malvern Treatments Centers addiction facilities and our new...

Read More

See All News

© 2020 Malvern Treatment Centers - All Rights Reserved | View Privacy Policy